Cardiol Therapeutics Financial Overview
Cardiol Therapeutics's market cap is currently C$142.00M. The company's EPS TTM is C$-0.12; its P/E ratio is -3.34; Cardiol Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is C$-0.12. See an overview of income statement, balance sheet, and cash flow financials.
